Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Ogawa, Hiroyasu  [Clear All Filters]
2023
Okinaka K, Inoue Y, Uchida N, Toya T, Ogawa H, Ozawa Y, Eto T, Mori T, Sugita J, Kondo T, et al. Clinical characteristics and risk factors of pneumococcal diseases in recipients of allogeneic hematopoietic stem cell transplants in the late phase: A retrospective registry study. J Infect Chemother. 2023.
Kaida K, Ikegame K, Inoue T, Maruyama S, Ishii S, Uchida N, Doki N, Eto T, Fukuda T, Katayama Y, et al. Peritransplant glucocorticoid haploidentical stem cell transplantation is a promising strategy for AML patients with high leukemic burden: Comparison with transplants using other donor types. Transplant Cell Ther. 2023.
2021
Inoue T, Koyama M, Kaida K, Ikegame K, Ensbey KS, Samson L, Takahashi S, Zhang P, Minnie SA, Maruyama S, et al. Peri-transplant glucocorticoids redistribute donor T-cells to the bone marrow and prevent relapse after haploidentical SCT. JCI Insight. 2021.
2020
Ikegame K, Kaida K, Fukunaga K, Osugi Y, Yoshihara K, Yoshihara S, Ishii S, Fujino S, Yamashita T, Mayumi A, et al. Allogeneic hematopoietic stem cell transplantation from a 2-HLA-haplotype-mismatched family donor for posttransplant relapse: a prospective phase I/II study. Bone Marrow Transplant. 2020.
Morishita S, Wakasugi T, Kaida K, Itani Y, Ikegame K, Ogawa H, Fujimori Y, Domen K. Relationship Between Exercise Capacity and Muscle OHb Saturation in Patients Before Hematopoietic Stem-Cell Transplantation. Adv Exp Med Biol. 2020;1232:215-221.
Wakasugi T, Morishita S, Kaida K, Itani Y, Ikegame K, Kodama N, Ogawa H, Fujimori Y, Domen K. Relationship Between Muscle Oxygen Saturation and Exercise Load in Patients with Malignant Hematopoietic Disease. Adv Exp Med Biol. 2020;1232:201-207.
2019
Tamaki H, Ikegame K, Yoshihara S, Kaida K, Yoshihara K, Inoue T, Kato R, Nakata J, Fujioka T, Soma T, et al. Low incidence of HHV-6 reactivation in haploidentical hematopoietic stem cell transplantation with corticosteroid as graft-versus-host disease prophylaxis compared with cord blood transplantation. Transpl Infect Dis. 2019:e13073.
2016
Ikegame K, Imai K, Yamashita M, Hoshino A, Kanegane H, Morio T, Kaida K, Inoue T, Soma T, Tamaki H, et al. Allogeneic stem cell transplantation for X-linked agammaglobulinemia using reduced intensity conditioning as a model of the reconstitution of humoral immunity. J Hematol Oncol. 2016;9(1):9.
2015
Morishita S, Kaida K, Yamauchi S, Wakasugi T, Ikegame K, Kodama N, Ogawa H, Domen K. Early-phase differences in health-related quality of life, psychological status, and physical function between human leucocyte antigen-haploidentical and other allogeneic haematopoietic stem cell transplantation recipients. Eur J Oncol Nurs. 2015.
2014
Yamahara K, Harada K, Ohshima M, Ishikane S, Ohnishi S, Tsuda H, Otani K, Taguchi A, Soma T, Ogawa H, et al. Comparison of angiogenic, cytoprotective, and immunosuppressive properties of human amnion- and chorion-derived mesenchymal stem cells. PLoS One. 2014;9(2):e88319.
Ueki S, Ikegame K, Kozawa M, Miyamoto J, Mori R, Ogawa H. Risk Analysis of Falls in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation. Clin J Oncol Nurs. 2014;18(4):396-399.
Kaida K, Ikegame K, Ikemoto J, Murata R, Irie R, Yoshihara S, Ishii S, Okada M, Inoue T, Tamaki H, et al. Soluble interleukin-2 receptor level on day 7 as a predictor of graft-versus-host disease after HLA-haploidentical stem cell transplantation using reduced-intensity conditioning. Int J Hematol. 2014.
2013
Kawakami M, Taniguchi K, Yoshihara S, Ishii S, Kaida K, Ikegame K, Okada M, Watanabe S, Nishina T, Hamada H, et al. Irreversible neurological defects in the lower extremities after haploidentical stem cell transplantation: Possible association with nelarabine. Am J Hematol. 2013.